Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
SG-23-1038904
Funder:
Alzheimer's Association
Funded outputs count:
138
Funder award ID:
SG-23-1038904
OpenAlex ID:
G2501682398
Spatiotemporal characterization of Alzheimer disease pathology in living human brain tissue
2026
·
Aram Aslanyan
, Soumya Mukherjee
, et al.
·
Nature Communications
·
1
PDF
Correlation of blood biomarkers with microstructural brain injury in survivors of out-of-hospital cardiac arrest
2026
·
Mikael V Laaksonen
, Jussi P Posti
, et al.
·
Brain Communications
PDF
CSF p-tau205: a biomarker of Alzheimer’s disease progression and biological staging
2026
·
Juan Lantero-Rodriguez
, Shorena Janelidze
, et al.
·
Molecular Psychiatry
PDF
Cerebrospinal fluid biomarkers reveal transdiagnostic synaptic dysfunction across major psychiatric disorders
2026
·
Andreas Göteson
, Johanna Nilsson
, et al.
·
Nature Communications
·
1
PDF
Spatiotemporal dynamics of tau extent and load increase in Alzheimer’s disease across four longitudinal cohorts
2026
·
Arthur C. Macedo
, Lydia Trudel
, et al.
·
Nature Aging
·
10
Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion Diseases
2026
·
Thomas Coysh
, Rhiannon Laban
, et al.
·
Neurology
·
3
Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation
2026
·
Alina Flintere-Flinte
, Vladimirs Krutovs
, et al.
·
BMC Neurology
GWAS meta-analysis of cerebrospinal fluid Alzheimer’s biomarkers reveals loci regulating lipids, brain volume and autophagy
2026
·
Jigyasha Timsina
, Chenyang Jiang
, et al.
·
Nature Communications
·
6
PDF
Cerebrospinal fluid and frontal cortex TMPRSS2 and ACE2 protein levels differ in Down syndrome and Alzheimer’s disease
2026
·
Carlos Avilés-Granados
, Adriana Gea-González
, et al.
·
Acta Neuropathologica Communications
Metabolic and renal factors associated with plasma phosphorylated tau analytes used to detect Alzheimer's disease pathology
2026
·
Kao Lee Yang
, Yue Ma
, et al.
·
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
·
2
Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer’s disease patients
2026
·
Adriana Gea-González
, Renata Valle-Pedroso
, et al.
·
Alzheimer s Research & Therapy
·
1
Aβ-related Cerebrospinal Fluid Proteins in Alzheimer’s Disease Reflect Gene Expression Levels Found in The Healthy Cortex
2026
·
Pedro Rosa-Neto
, Seyyed Ali Hosseini
, et al.
·
Research Square
PDF
Physical activity across the life course and neural biomarkers
2026
·
Elisa R. Torres
, Eloise D. Lopez
, et al.
·
Journal of Alzheimer s Disease
Biomarker-integrated prognostic stagings for Alzheimer’s Disease
2026
·
Daeun Shin
, Sungjoo Lee
, et al.
·
Nature Communications
·
6
PDF
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia
2026
·
Jihwan Yun
, Jungah Lee
, et al.
·
JAMA Neurology
·
18
PDF
N‐Truncated Superoxide Dismutase‐1 in Cerebrospinal Fluid Is Folded and Active
2026
·
Laura Leykam
, Karin M. E. Forsberg
, et al.
·
Journal of Neurochemistry
PDF
Glymphatic dysfunction links vascular pathology to Alzheimer’s biomarkers and cognitive decline
2026
·
Sung Hoon Kang
, Seongmi Kim
, et al.
·
Alzheimer s Research & Therapy
·
10
Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer’s disease mutations
2026
·
Emma S. Luckett
, Mariola Zapater-Fajari
, et al.
·
Translational Psychiatry
·
1
PDF
Cerebrospinal fluid levels of neurogranin and YKL-40 in mild cognitive impairment due to Alzheimer's disease or vascular dementia
2026
·
Ulla Andin
, Svante Lifvergren
, et al.
·
Journal of Alzheimer s Disease
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
2026
·
Hanna Huber
, Laia Montoliu-Gaya
, et al.
·
Nature Medicine
·
41
PDF
Increased cerebrospinal fluid YKL-40 concentration in hip fracture patients with delirium
2026
·
Thea Berntsen
, Kaj Blennow
, et al.
·
Brain Communications
·
1
PDF
Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
2026
·
Frederikke Kragh Clemmensen
, Mathias Holsey Gramkow
, et al.
·
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Integrative analysis of AT classification, plasma biomarkers, and cognitive trajectories across diverse dementia syndromes
2025
·
Jihwan Yun
, Min Young Chun
, et al.
·
Scientific Reports
·
1
PDF
Clinicopathological and prognostic correlations of plasma biomarkers in neurodegenerative diseases
2025
·
Maura Malpetti
, Leonidas Chouliaras
, et al.
·
medRxiv
·
2
PDF
Saliva phosphorylated tau concentration is not associated with Alzheimer’s disease, cerebrospinal fluid or blood biomarkers
2025
·
Helena Sophia Gleerup
, Federica Sanna
, et al.
·
Frontiers in Neuroscience
·
2
PDF
Show more works
View as search